Last quarter (Q3 2023), HLS Therapeutics Inc's total revenue was $16.04M, an increase of 3.25% from the same quarter last year. In Q3, HLS Therapeutics Inc's net income was $-6.90M. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 62.89M	$ 61.47M	$ 60.01M	$ 56.11M	$ 54.16M	$ 61.41M
Cost of Revenue	$ 3.57M	$ 4.98M	$ 3.97M	$ 3.63M	$ 1.93M	$ 2.60M
Gross Profit	$ 56.28M	$ 56.49M	$ 56.04M	$ 52.48M	$ 52.23M	$ 58.82M
Operating Expense	$ 34.28M	$ 70.78M	$ 62.32M	$ 64.57M	$ 56.86M	$ 51.18M
Operating Income	$ -15.68M	$ -14.29M	$ -6.28M	$ -12.09M	$ -4.63M	$ 7.64M
Net Non Operating Interest Income Expense	$ -9.95M	$ -7.26M	$ 6.91M	$ -5.99M	$ -7.11M	$ -35.70M
Other Income Expense	$ 1.23M	$ -2.33M	$ 1.39M	$ 1.77M	$ -8.72M	$ -737.00K
Pretax Income	$ -29.00M	$ -23.72M	$ -11.81M	$ -16.30M	$ -20.46M	$ -28.80M
Tax Provision	$ -252.00K	$ -124.00K	$ 1.31M	$ -968.00K	$ -911.00K	$ -4.00M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -28.56M	$ -23.60M	$ -13.12M	$ -15.33M	$ -19.55M	$ -24.81M
Basic EPS	$ -0.88	$ -0.73	$ -0.41	$ -0.48	$ -0.67	$ -0.92
Diluted EPS	$ -0.88	$ -0.73	$ -0.41	$ -0.48	$ -0.67	$ -0.92
Basic Average Shares	$ 129.39M	$ 32.43M	$ 32.18M	$ 31.71M	$ 29.36M	$ 26.95M
Diluted Average Shares	$ 129.39M	$ 32.43M	$ 32.18M	$ 31.71M	$ 29.36M	$ 26.95M
Dividend Per Share	$ 0.05	$ 0.05	$ 0.16	$ 0.15	$ 0.15	$ 0.04
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 37.85M	$ 75.76M	$ -66.29M	$ 68.20M	$ 58.79M	$ 53.78M
Net Income From Continuing And Discontinued Operation	$ -28.56M	$ -23.60M	$ -13.12M	$ -15.33M	$ -19.55M	$ -24.81M
Normalized Income	$ -24.74M	$ -19.45M	$ -8.51M	$ -16.52M	$ -11.22M	$ -24.17M
Interest Expense	-	-	-	$ 6.31M	$ 7.70M	$ 17.11M
EBIT	$ -21.14M	$ -16.41M	$ -4.85M	$ -9.99M	$ -12.76M	$ -11.69M
EBITDA	$ 8.35M	$ 18.00M	$ 25.41M	$ 23.19M	$ 19.75M	$ 20.70M

Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing